Analyst Ratings For NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
Today, NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) stock was downgraded by Jefferies Financial Group from Buy ➝ Hold to .
Some recent analyst ratings include
- 6/13/2018-Jefferies Financial Group was Downgraded by analysts at Jefferies Financial Group from a “Buy ➝ Hold” rating to a “” rating.
- 5/10/2018-Robert W. Baird was Downgraded by analysts at Robert W. Baird from a “Outperform ➝ Neutral” rating to a “” rating. They now have a $67.00 price target on the stock.
- 5/10/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $75.00 price target on the stock.
- 5/10/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $50.00 price target on the stock.
Recent Trading Activity for NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
Shares of NASDAQ:ARMO – ARMO BioSciences closed the previous trading session at 49.97 +0.00 0.00% with 49.959999084472656 shares trading hands.